Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The conjugation reaction of monoclonal antibodies (mAbs) with small-molecule drugs is a central step during production of antibody-drug conjugates (ADCs). Antibody-drug conjugates (ADCs) are a class of drugs designed as a targeted therapy for treating disease, but at the moment are widely used for the management or treatment of cancer. They are complex molecules consisting of an antibody linked to a biologically active cytotoxic payload or drug.